Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00343070
Status:
COMPLETED
Last Update Posted:
2010-08-31
First Post:
2006-06-19
Brief Title:
Functional Neuroimaging in Depression
Sponsor:
University Hospital Ghent
Organization:
University Hospital Ghent
Study Overview
Official Title:
Functional Neuroimaging in Depression Longitudinal Study of PET Metabolism in Correlation With Changes in Attentional Bias Autobiographical Memory Future Fluency and Facial Recognition in Depressed Patients Treated With Escitalopram
Status:
COMPLETED
Status Verified Date:
2010-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Oral administration of escitalopram during 8 weeks PET scan with 18F-FDG at inclusion and after 8 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None